Evidence map›Paper›PMID 32646031›Full record

ReviewCells2020

Chemical Modulation of Mitochondria-Endoplasmic Reticulum Contact Sites.

Ana Paula Magalhães Rebelo, Federica Dal Bello, Tomas Knedlik, Natasha Kaar, Fabio Volpin, Sang Hun Shin, Marta Giacomello

Abstract readReview
In one paragraph

Review in Cells, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 24 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
24citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

24 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Review
  3. Review
  4. Organelle contact sites in cancer cells.Cell death & disease · 2026
    Review
  5. Review
  6. Review
  7. Review
  8. Article
  9. Review
  10. Review
  11. Altered Protein Palmitoylation as Disease Mechanism in Neurodegenerative Disorders.The Journal of neuroscience : the official journal of the Society for Neuroscience · 2024
    Review
  12. Article
  13. Article
  14. Review
  15. Review
  16. Review
  17. Review
  18. Review
  19. Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Ana Paula Magalhães RebeloDepartment of Biology, University of Padua, Via U. Bassi 58/B, 35121 Padua, Italy.ORCID 0000-0001-8811-4181
Federica Dal BelloDepartment of Biology, University of Padua, Via U. Bassi 58/B, 35121 Padua, Italy.ORCID 0000-0002-9323-955X
Tomas KnedlikDepartment of Biology, University of Padua, Via U. Bassi 58/B, 35121 Padua, Italy.ORCID 0000-0001-7162-6631
Natasha KaarDepartment of Biology, University of Padua, Via U. Bassi 58/B, 35121 Padua, Italy.
Fabio VolpinDepartment of Biology, University of Padua, Via U. Bassi 58/B, 35121 Padua, Italy.
Sang Hun ShinDepartment of Biology, University of Padua, Via U. Bassi 58/B, 35121 Padua, Italy.
Marta GiacomelloDepartment of Biology, University of Padua, Via U. Bassi 58/B, 35121 Padua, Italy.ORCID 0000-0002-0290-6602

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Contact sites between mitochondria and endoplasmic reticulum (ER) are points in which the two organelles are in close proximity. Due to their structural and functional complexity, their exploitation as pharmacological targets has never been considered so far. Notwithstanding, the number of compounds described to target proteins residing at these interfaces either directly or indirectly is rising. Here we provide original insight into mitochondria-ER contact sites (MERCs), with a comprehensive overview of the current MERCs pharmacology. Importantly, we discuss the considerable potential of MERCs to become a druggable target for the development of novel therapeutic strategies.

Indexed as

AnimalsEndoplasmic ReticulumHumansMitochondriaMitochondrial Membranescancerdiabetesdrug targetsmitochondria-associated membranesmitochondria–endoplasmic reticulum contact sitesneurodegenerationpharmacologysynthetic and biological compounds

Identifiers

PMID32646031
PMCPMC7408517

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.